A Study of Stereotactic Body Radiotherapy (SBRT) and Surgical Stabilization for People With Cancer That Has Spread to the Bone

StatusCompleted
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial completed
    • Primary completion date changed from estimate of Jun 2027 to Sep 17, 2026
    • Eligibility criteria expanded, about 19 words
    • Publications: details revised at 1 of 1 entry
  2. Primary and study completion dates: Jun 2026 to Jun 2027v12
  3. Primary and study completion dates: Jul 2026 to Jun 2026
    • Start date: Jul 30, 2021 to Jun 30, 2021
    • Site details revised at 1 of 7 sites
    v11
  4. Primary and study completion dates: Jul 2025 to Jul 2026
    • Site details revised at 1 of 7 sites
    v10
  5. Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 40 to confirmed 39
    • Site details revised at 7 of 7 sites
    v9
Show 7 earlier versionsHide 7 earlier versions
  1. Primary and study completion dates: Jul 2024 to Jul 2025v8
  2. Re-verified, no change to tracked fieldsv7
  3. Eligibility criteria expanded, about 8 wordsv6
  4. Study sites revised (7)v5
  5. Enrollment target: 34 to 40v4
  6. Primary and study completion dates: Jul 2023 to Jul 2024
    • Study sites revised (7)
    v3
  7. Eligibility criteria shortened, about 5 wordsv2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to test the safety of stereotactic body radiation therapy (SBRT) followed by surgical stabilization within 1 week. All participants will have metastatic cancer in the bone (bone metastases), and they will be at risk of pathologic fracture (broken bone caused by a disease). Another purpose of this study is to see if the treatment approach of SBRT followed by surgical stabilization within 1 week prevents cancer from returning to the bone.
Trial Details
NCT Number NCT05038124
Lead Sponsor Memorial Sloan Kettering Cancer Center
Conditions
(from sponsor)		 Metastatic Cancer
Related terms Bone Neoplasms, Neoplasm Metastasis
Enrollment 39 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov